‏‏evaluation of the activity of liver enzymes and some biochemical variables in pregnant women infected with COVID-19 in Kirkuk governorate‏‏‏‏

Some hematological and biochemical markers were measured in COVID19 patients (pregnant women) as part of the research. 60 pregnant women with COVID-19 infection and 30 control subjects were included in this study. Research was carried out at Kirkuk's hospitals between January 2022 and April 2022. The following is a breakdown of the participants: Pregnant women in the first group: 30 healthy women. In the second group, 30 samples were taken from infected pregnant women aged 18 to 30 years old. Pregnant women between the ages of 30 and 40 are in the third group, which includes 30 samples. RBC count, Hb concentration, PCV/MCV ratio, and percentage of MCV decreased significantly (P 0.05) in patients compared to control group. Patients' WBC and neutrophil and lymphocyte percentages rose significantly (P 0.05), whereas their lymphocyte and neutrophil percentages decreased significantly (P 0.05). Otherwise, the proportion of eosinophils, monocytes, and basophils in patients (15.71±2.18) compared to the control group indicates no significant differences (P 0.05). Patients' levels of liver enzymes were found to be significantly (P 0.05) elevated. Finally, the findings revealed that patients' levels of total protein, albumin, and vitamin D3 were significantly decreased (P 0.05). Keywords: COVID19, Liver enzymes, Vitamin D3, Total protein, Albumin